451 related articles for article (PubMed ID: 24969637)
1. Potentiation of pH-sensitive polymer-modified liposomes with cationic lipid inclusion as antigen delivery carriers for cancer immunotherapy.
Yoshizaki Y; Yuba E; Sakaguchi N; Koiwai K; Harada A; Kono K
Biomaterials; 2014 Sep; 35(28):8186-96. PubMed ID: 24969637
[TBL] [Abstract][Full Text] [Related]
2. pH-sensitive polymer-modified liposome-based immunity-inducing system: Effects of inclusion of cationic lipid and CpG-DNA.
Yoshizaki Y; Yuba E; Sakaguchi N; Koiwai K; Harada A; Kono K
Biomaterials; 2017 Oct; 141():272-283. PubMed ID: 28704679
[TBL] [Abstract][Full Text] [Related]
3. A liposome-based antigen delivery system using pH-sensitive fusogenic polymers for cancer immunotherapy.
Yuba E; Harada A; Sakanishi Y; Watarai S; Kono K
Biomaterials; 2013 Apr; 34(12):3042-52. PubMed ID: 23374704
[TBL] [Abstract][Full Text] [Related]
4. pH-sensitive polymer-liposome-based antigen delivery systems potentiated with interferon-γ gene lipoplex for efficient cancer immunotherapy.
Yuba E; Kanda Y; Yoshizaki Y; Teranishi R; Harada A; Sugiura K; Izawa T; Yamate J; Sakaguchi N; Koiwai K; Kono K
Biomaterials; 2015 Oct; 67():214-24. PubMed ID: 26222284
[TBL] [Abstract][Full Text] [Related]
5. Dextran derivative-based pH-sensitive liposomes for cancer immunotherapy.
Yuba E; Tajima N; Yoshizaki Y; Harada A; Hayashi H; Kono K
Biomaterials; 2014 Mar; 35(9):3091-101. PubMed ID: 24406217
[TBL] [Abstract][Full Text] [Related]
6. The application of pH-sensitive polymer-lipids to antigen delivery for cancer immunotherapy.
Yuba E; Kono Y; Harada A; Yokoyama S; Arai M; Kubo K; Kono K
Biomaterials; 2013 Jul; 34(22):5711-21. PubMed ID: 23639528
[TBL] [Abstract][Full Text] [Related]
7. Improvement of Peptide-Based Tumor Immunotherapy Using pH-Sensitive Fusogenic Polymer-Modified Liposomes.
Yoshizaki Y; Yuba E; Komatsu T; Udaka K; Harada A; Kono K
Molecules; 2016 Sep; 21(10):. PubMed ID: 27681717
[TBL] [Abstract][Full Text] [Related]
8. pH-Sensitive fusogenic polymer-modified liposomes as a carrier of antigenic proteins for activation of cellular immunity.
Yuba E; Kojima C; Harada A; Tana ; Watarai S; Kono K
Biomaterials; 2010 Feb; 31(5):943-51. PubMed ID: 19850335
[TBL] [Abstract][Full Text] [Related]
9. Bioactive polysaccharide-based pH-sensitive polymers for cytoplasmic delivery of antigen and activation of antigen-specific immunity.
Yuba E; Yamaguchi A; Yoshizaki Y; Harada A; Kono K
Biomaterials; 2017 Mar; 120():32-45. PubMed ID: 28027502
[TBL] [Abstract][Full Text] [Related]
10. Modifying Antigen-Encapsulating Liposomes with KALA Facilitates MHC Class I Antigen Presentation and Enhances Anti-tumor Effects.
Miura N; Akita H; Tateshita N; Nakamura T; Harashima H
Mol Ther; 2017 Apr; 25(4):1003-1013. PubMed ID: 28236573
[TBL] [Abstract][Full Text] [Related]
11. Preparation of glycopeptide-modified pH-sensitive liposomes for promoting antigen cross-presentation and induction of antigen-specific cellular immunity.
Yuba E; Gupta RK
Biomater Sci; 2024 Mar; 12(6):1490-1501. PubMed ID: 38329387
[TBL] [Abstract][Full Text] [Related]
12. The pH-sensitive fusogenic 3-methyl-glutarylated hyperbranched poly(glycidol)-conjugated liposome induces antigen-specific cellular and humoral immunity.
Hebishima T; Yuba E; Kono K; Takeshima SN; Ito Y; Aida Y
Clin Vaccine Immunol; 2012 Sep; 19(9):1492-8. PubMed ID: 22815149
[TBL] [Abstract][Full Text] [Related]
13. A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy.
Suzuki R; Oda Y; Utoguchi N; Namai E; Taira Y; Okada N; Kadowaki N; Kodama T; Tachibana K; Maruyama K
J Control Release; 2009 Feb; 133(3):198-205. PubMed ID: 19000727
[TBL] [Abstract][Full Text] [Related]
14. Gene delivery to dendritic cells mediated by complexes of lipoplexes and pH-sensitive fusogenic polymer-modified liposomes.
Yuba E; Kojima C; Sakaguchi N; Harada A; Koiwai K; Kono K
J Control Release; 2008 Aug; 130(1):77-83. PubMed ID: 18573563
[TBL] [Abstract][Full Text] [Related]
15. Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes.
Nakamura T; Moriguchi R; Kogure K; Shastri N; Harashima H
Mol Ther; 2008 Aug; 16(8):1507-14. PubMed ID: 18560420
[TBL] [Abstract][Full Text] [Related]
16. Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens.
Gao J; Ochyl LJ; Yang E; Moon JJ
Int J Nanomedicine; 2017; 12():1251-1264. PubMed ID: 28243087
[TBL] [Abstract][Full Text] [Related]
17. NLRP3 inflammasome-activating arginine-based liposomes promote antigen presentations in dendritic cells.
Li T; Zehner M; He J; Próchnicki T; Horvath G; Latz E; Burgdorf S; Takeoka S
Int J Nanomedicine; 2019; 14():3503-3516. PubMed ID: 31190807
[No Abstract] [Full Text] [Related]
18. Carboxylated hyperbranched poly(glycidol)s for preparation of pH-sensitive liposomes.
Yuba E; Harada A; Sakanishi Y; Kono K
J Control Release; 2011 Jan; 149(1):72-80. PubMed ID: 20206654
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cells that endocytosed antigen-containing IgG-liposomes elicit effective antitumor immunity.
Kawamura K; Kadowaki N; Suzuki R; Udagawa S; Kasaoka S; Utoguchi N; Kitawaki T; Sugimoto N; Okada N; Maruyama K; Uchiyama T
J Immunother; 2006; 29(2):165-74. PubMed ID: 16531817
[TBL] [Abstract][Full Text] [Related]
20. Preparation of pH-sensitive poly(glycidol) derivatives with varying hydrophobicities: their ability to sensitize stable liposomes to pH.
Sakaguchi N; Kojima C; Harada A; Kono K
Bioconjug Chem; 2008 May; 19(5):1040-8. PubMed ID: 18419148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
